MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

Autor: Vera-Puente, Olga, Rodriguez-Antolin, Carlos, Salgado-Figueroa, Ana, Michalska, Patrycja, Pernia, Olga, Reid, Brett M., Rosas, RocÍo, Garcia-Guede, Alvaro, SacristÁn, Silvia, Jimenez, Julia, Esteban-Rodriguez, Isabel, Martin, M. Elena, Sellers, Thomas A., León, Rafael, Gonzalez, VÍctor M., De Castro, Javier, Ibanez de Caceres, Inmaculada
Zdroj: In Translational Research October 2018 200:1-17
Databáze: ScienceDirect
Externí odkaz: